ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Movember movement against prostate cancer: much more than moustaches

30/10/2020|Comments Off on Movember movement against prostate cancer: much more than moustaches

VHIO in 2019: tick tock toward 2025

28/10/2020|Comments Off on VHIO in 2019: tick tock toward 2025

Cerebrospinal fluid as liquid biopsy for the precise characterization and policing of medulloblastoma

27/10/2020|Comments Off on Cerebrospinal fluid as liquid biopsy for the precise characterization and policing of medulloblastoma

A new medication for acute myeloid leukaemia shows positive results in a first-in-human clinical trial

22/10/2020|Comments Off on A new medication for acute myeloid leukaemia shows positive results in a first-in-human clinical trial

Immune-based therapy promises a new therapeutic avenue for patients with advanced or recurrent endometrial cancer

13/10/2020|Comments Off on Immune-based therapy promises a new therapeutic avenue for patients with advanced or recurrent endometrial cancer

Immunotherapy gains ground as an alternative for cancer treatment

21/09/2020|Comments Off on Immunotherapy gains ground as an alternative for cancer treatment

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2019

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER (UITM) – “LA CAIXA” FOUNDATION
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS